Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R. Lentz

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 25, 2018
Once-weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9-GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trialsJohannes Oldenburg, Manuel Carcao, Steven R Lentz, et al.
Cell Stem Cell|August 29, 2017
Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1Fengyin Li, Bing He, Xiaoke Ma, et al.
Blood|November 1, 2024
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemiaEloy Roman, Bruno Fattizzo, Merrill Shum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2015
Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expressionHong Jin, Milena A Gebska, Ilya O Blokhin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 8, 2021
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trialUsha S Perepu, Isaac Chambers, Abdul Wahab, et al.
The Journal of Clinical Investigation|November 26, 2019
Smooth muscle cell-specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasiaManish Jain, Nirav Dhanesha, Prakash Doddapattar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2006
Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regressionSotirios Tsimikas, Masanori Aikawa, Francis J Miller, et al.
Circulation Research|March 21, 2020
Targeting Myeloid-Specific Integrin α9β1 Improves Short- and Long-Term Stroke Outcomes in Murine Models With Preexisting Comorbidities by Limiting Thrombosis and InflammationNirav Dhanesha, Manish Jain, Amit K Tripathi, et al.
Blood Advances|April 19, 2019
Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in miceVijay K Sonkar, Rahul Kumar, Melissa Jensen, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia APratima Chowdary, Manuel Carcao, Pål A Holme, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 25, 2018
Once-weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9-GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trialsJohannes Oldenburg, Manuel Carcao, Steven R Lentz, et al.
Cell Stem Cell|August 29, 2017
Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1Fengyin Li, Bing He, Xiaoke Ma, et al.
Blood|November 1, 2024
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemiaEloy Roman, Bruno Fattizzo, Merrill Shum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2015
Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expressionHong Jin, Milena A Gebska, Ilya O Blokhin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 8, 2021
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trialUsha S Perepu, Isaac Chambers, Abdul Wahab, et al.
The Journal of Clinical Investigation|November 26, 2019
Smooth muscle cell-specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasiaManish Jain, Nirav Dhanesha, Prakash Doddapattar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2006
Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regressionSotirios Tsimikas, Masanori Aikawa, Francis J Miller, et al.
Circulation Research|March 21, 2020
Targeting Myeloid-Specific Integrin α9β1 Improves Short- and Long-Term Stroke Outcomes in Murine Models With Preexisting Comorbidities by Limiting Thrombosis and InflammationNirav Dhanesha, Manish Jain, Amit K Tripathi, et al.
Blood Advances|April 19, 2019
Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in miceVijay K Sonkar, Rahul Kumar, Melissa Jensen, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia APratima Chowdary, Manuel Carcao, Pål A Holme, et al.
Pageof 12